Impact of cumulative dose and time on magnetic resonance imaging and clinical outcomes during long-term treatment with subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: exploratory analyses

A. Traboulsee, C. Constantinescu, L. Kappos, D. Ll, M. Sandberg, B. Uitdehaag, J. Gardner, E. Verdun

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)S126-S127
JournalMultiple Sclerosis Journal
Volume15
Issue number9
Publication statusPublished - 2009
Externally publishedYes
Event25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis - Dusseldorf, Germany
Duration: 2009 Sept 92009 Sept 12

Subject classification (UKÄ)

  • Neurology

Cite this